NanoGuardian announces John Glover to lead security advisory board

NanoGuardian, a division of NanoInk that focuses on delivering brand protection solutions to fight illegal diversion and counterfeiting, has announced that John D. Glover, D.P.A., has been appointed to lead its Security Advisory Board.

With a distinguished career spanning more than 35 years with the FBI, Bristol-Myers Squibb Company, the Pharmaceutical Security Institute and the U.S. State Department, Dr. Glover will advise NanoGuardian in its efforts to curb the spread of counterfeit and diverted pharmaceuticals in the supply chain.

Today, Dr. Glover serves as president of John Glover Consulting, Inc., which provides consulting services to a very select number of prominent corporate and non-governmental entities. “After 35 years of working complex investigations, some of which included chasing counterfeiters and diverters with the FBI, NanoGuardian's on-dose NanoEncryption‘ technology is a product that I can get excited about,” said Dr. Glover.
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026